BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 990 filers reported holding BAXTER INTL INC in Q4 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,172,004 | +7.9% | 22,994 | +14.1% | 0.04% | +16.1% |
| Q3 2022 | $1,086,000 | -23.3% | 20,156 | -8.6% | 0.03% | -29.5% |
| Q2 2022 | $1,416,000 | +5.8% | 22,043 | +27.7% | 0.04% | +22.2% |
| Q1 2022 | $1,339,000 | -71.3% | 17,264 | -68.3% | 0.04% | -59.6% |
| Q4 2021 | $4,670,000 | +291.1% | 54,406 | +266.5% | 0.09% | +81.6% |
| Q3 2021 | $1,194,000 | -3.6% | 14,845 | -3.4% | 0.05% | +16.7% |
| Q2 2021 | $1,238,000 | -18.3% | 15,374 | -14.5% | 0.04% | -12.5% |
| Q1 2021 | $1,516,000 | +19.3% | 17,976 | +13.4% | 0.05% | +23.1% |
| Q4 2020 | $1,271,000 | +19.8% | 15,846 | +20.2% | 0.04% | +14.7% |
| Q3 2020 | $1,061,000 | -33.0% | 13,188 | -28.3% | 0.03% | -37.0% |
| Q2 2020 | $1,584,000 | -15.7% | 18,393 | -20.5% | 0.05% | -27.0% |
| Q1 2020 | $1,880,000 | -60.1% | 23,150 | -58.9% | 0.07% | -12.9% |
| Q4 2019 | $4,710,000 | -2.4% | 56,332 | +2.1% | 0.08% | +2.4% |
| Q3 2019 | $4,825,000 | +5.0% | 55,165 | -1.7% | 0.08% | +1.2% |
| Q2 2019 | $4,597,000 | +13.0% | 56,134 | +12.2% | 0.08% | -25.5% |
| Q1 2019 | $4,067,000 | +24.8% | 50,016 | +1.0% | 0.11% | +2.8% |
| Q4 2018 | $3,260,000 | +182.5% | 49,530 | +159.8% | 0.11% | +75.4% |
| Q2 2017 | $1,154,000 | -70.0% | 19,068 | -74.3% | 0.06% | -73.8% |
| Q1 2017 | $3,853,000 | +99.4% | 74,294 | +70.5% | 0.23% | +100.9% |
| Q4 2016 | $1,932,000 | -65.4% | 43,579 | -62.9% | 0.12% | -70.6% |
| Q3 2016 | $5,584,000 | -24.5% | 117,310 | -28.3% | 0.39% | -18.6% |
| Q2 2016 | $7,398,000 | -6.1% | 163,610 | -14.7% | 0.48% | -28.7% |
| Q1 2016 | $7,877,000 | +301.7% | 191,756 | +273.1% | 0.68% | +263.1% |
| Q4 2015 | $1,961,000 | -26.5% | 51,400 | -36.7% | 0.19% | -32.0% |
| Q3 2015 | $2,667,000 | +15.4% | 81,192 | +145.7% | 0.28% | +33.5% |
| Q2 2015 | $2,311,000 | -41.4% | 33,051 | -42.6% | 0.21% | -37.6% |
| Q1 2015 | $3,946,000 | +7.5% | 57,611 | +15.1% | 0.33% | +17.4% |
| Q4 2014 | $3,669,000 | -49.3% | 50,064 | -50.4% | 0.28% | -14.6% |
| Q3 2014 | $7,238,000 | -44.1% | 100,843 | -43.7% | 0.33% | -6.0% |
| Q2 2014 | $12,952,000 | +50.0% | 179,136 | +52.7% | 0.35% | +25.9% |
| Q1 2014 | $8,633,000 | +63.8% | 117,334 | +54.9% | 0.28% | +42.6% |
| Q4 2013 | $5,269,000 | +5.9% | 75,755 | 0.0% | 0.20% | +1.0% |
| Q3 2013 | $4,976,000 | -5.2% | 75,755 | 0.0% | 0.19% | -19.2% |
| Q2 2013 | $5,248,000 | – | 75,755 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |